Competition in State Healthcare Markets Act
The source supplies the latest action, but no lifecycle stage.
Latest action (27 Aug 2026): Referred to the House Committee on Energy and Commerce.
What this bill does
H.R. 10177, the Competition in State Healthcare Markets Act, would direct the Assistant Secretary for Planning and Evaluation (ASPE) at the Department of Health and Human Services to conduct an annual study, over each of the ten years after enactment, on health care competition and consolidation at the state level. The Assistant Secretary would consult with the Federal Trade Commission and the Justice Department's Antitrust Division, and could request data from the FTC. The study would track metrics such as licensing requirements for health practitioners, mergers and acquisitions among hospitals, outpatient practices, insurers, and other providers, state certificate-of-public-advantage and certificate-of-need laws, availability of short-term and association health plans, counts of health care entities, and market concentration measures (Herfindahl-Hirschman Index) for certain services.
The bill primarily affects federal agencies (HHS, FTC, DOJ) by creating new reporting and data-collection duties; it does not regulate private businesses or individuals directly, but the resulting data could inform future policy on health care markets, providers, and insurers. Each year, ASPE would report findings to specified House and Senate committees and publish the reports and underlying data publicly online.
The bill was introduced on August 27, 2026, by Rep. Victoria Spartz and referred to the House Committee on Energy and Commerce. It has not yet been voted on or advanced further in the legislative process.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
27 Aug 2026
Referred to the House Committee on Energy and Commerce.
Common questions
- What does H.R. 10177 do?
- H.R. 10177, the Competition in State Healthcare Markets Act, would direct the Assistant Secretary for Planning and Evaluation (ASPE) at the Department of Health and Human Services to conduct an annual study, over each of the ten years after enactment, on health care competition and consolidation at the state level. The Assistant Secretary would consult with the Federal Trade Commission and the Justice Department's Antitrust Division, and could request data from the FTC. The study would track metrics such as licensing requirements for health practitioners, mergers and acquisitions among hospitals, outpatient practices, insurers, and other providers, state certificate-of-public-advantage and certificate-of-need laws, availability of short-term and association health plans, counts of health care entities, and market concentration measures (Herfindahl-Hirschman Index) for certain services. The bill primarily affects federal agencies (HHS, FTC, DOJ) by creating new reporting and data-collection duties; it does not regulate private businesses or individuals directly, but the resulting data could inform future policy on health care markets, providers, and insurers. Each year, ASPE would report findings to specified House and Senate committees and publish the reports and underlying data publicly online. The bill was introduced on August 27, 2026, by Rep. Victoria Spartz and referred to the House Committee on Energy and Commerce. It has not yet been voted on or advanced further in the legislative process.
- Has H.R. 10177 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 10177. Check the latest action and official source below.
- Who sponsored H.R. 10177?
- H.R. 10177 was sponsored by Rep. Spartz, Victoria [R-IN-5] (R-IN), with 0 cosponsors.
- What's the latest action on H.R. 10177?
- Referred to the House Committee on Energy and Commerce. (27 Aug 2026).
Related bills in Health
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Choices for Increased Mobility Act of 2026
Lower Premiums, Faster Payments Act
Access to Medical Supplies Act
More bills from Rep. Spartz, Victoria [R-IN-5]
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.